Just days after the Food and Drug Administration approved Otezla, a new oral therapy to treat active psoriatic arthritis in adult patients, Avella Specialty Pharmacy on Friday announced that it is prepared to begin distributing the drug.
The National Psoriasis Foundation and the Arthritis Foundation are presenting the country's first program specifically devoted to psoriatic arthritis this week, the two organizations said Monday.
Two organizations are providing an educational program centered on a serious form of arthritis that affects up to 2 million people in the United States.
Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat active psoriatic arthritis, the company said Thursday.
The National Psoriasis Foundation has introduced a Seal of Recognition that will be touted on select products that dermatology experts deem effective in relieving disease symptoms.